Drug Information

Drug General Information
Drug ID
D08ANZ
Drug Name
Pembrolizumab
Drug Type
Monoclonal antibody
Indication Melanoma [ICD10:C43-C44] Approved [556264]
Discovery agent Investigative [1572605]
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
Ref 1572605The ChEMBL database in 2017.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.